Prolonged elevated heart rate is a risk factor for adverse cardiac events and poor outcome after subarachnoid hemorrhage

Neurocritical Care

Volumn 20, Issue 3, 2014, Pages 390-398

  Schmidt, J Michael ^a   Crimmins, Michael ^a   Lantigua, Hector ^a   Fernandez, Andres ^a   Zammit, Chris ^a   Falo, Cristina ^a   Agarwal, Sachin ^a   Claassen, Jan ^a   Mayer, Stephan A ^a  

^a Milstein Hospital   (United States)

Author keywords

Cardiopulmonary complications; Functional outcome; Heart rate; Subarachnoid hemorrhage

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; TROPONIN;

ADULT; APACHE; ARTICLE; BRAIN ISCHEMIA; BRAIN VASOSPASM; CONTROLLED STUDY; DELAYED CEREBRAL ISCHEMIA; FEMALE; HEART DISEASE; HEART MUSCLE INJURY; HEART RATE; HUMAN; HUNT HESS GRADE; HYPERTENSION; HYPOTENSION; INTENSIVE CARE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MODIFIED FISHER SCORE; PRIORITY JOURNAL; PROGNOSIS; PROLONGED HEART RATE ELEVATION; RANKIN SCALE; SCORING SYSTEM; SUBARACHNOID HEMORRHAGE; ACUTE DISEASE; ADRENERGIC SYSTEM; AGED; CONSCIOUSNESS DISORDERS; DRUG EFFECTS; ELECTROCARDIOGRAPHY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK FACTOR; TACHYCARDIA; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BRAIN ISCHEMIA; CONSCIOUSNESS DISORDERS; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SUBARACHNOID HEMORRHAGE; SYMPATHETIC NERVOUS SYSTEM; TACHYCARDIA; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 84902368686     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-013-9909-z     Document Type: Article

References (32)

1. Cruickshank J, Neil-Dwyer G, Stott A. Possible role of catecholamines, corticosteroids, and potassium in production of electrocardiographic abnormalities associated with subarachnoid haemorrhage. Br Heart J. 1974;36:697.
2. Dilraj A, Botha JH, Rambiritch V, Miller R, van Dellen JR. Levels of catecholamine in plasma and cerebrospinal fluid in aneurysmal subarachnoid hemorrhage. Neurosurgery. 1992;31:42.
3. Grad A, Kiauta T, Osredkar J. Effect of elevated plasma norepinephrine on electrocardiographic changes in subarachnoid hemorrhage. Stroke. 1991;22:746-9.
4. Naredi S, Lambert G, Eden E, et al. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke. 2000;31:901-6. (Pubitemid 30198436)
5. Cruickshank J, Neil-Dwyer G, Lane J. The effect of oral propranolol upon the ECG changes occurring in subarachnoid haemorrhage. Cardiovasc Res. 1975;9:236-45.
6. Naidech AM, Kreiter KT, Janjua N, et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005;112:2851.
7. Temes RE, Schmidt JM, Naidech AM, et al. Association of severe left ventricular dysfunction after SAH with stroke from delayed vasospasm and functional outcome among patients. In: 3rd annual meeting of the neurocritical care society (platform presentation). Pheonix: Neurocrit Care; 2005 p. 2.
8. Muroi C, Keller M, Pangalu A, Fortunati M, Yonekawa Y, Keller E. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008;20:188-92.
9. Frontera JA, Parra A, Shimbo D, et al. Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome. Cerebrovasc Dis. 2008;26:71-8. (Pubitemid 351931423)
10. Banki NM, Kopelnik A, Dae MW, et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation. 2005;112:3314-9. (Pubitemid 43739377)
11. Brouwers PJ, Westenberg H, Van Gijn J. Noradrenaline concentrations and electrocardiographic abnormalities after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1995; 58:614-7.
12. Crago E, Kerr M, Kong Y, et al. The impact of cardiac complications on outcome in the SAH population. Acta Neurol Scand. 2004;110:248-53. (Pubitemid 39274060)
13. Mayer S, Fink M, Homma S, et al. Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage. Neurology. 1994;44:815.
14. Sander O, Welters ID, Foëx P, Sear JW. Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications*. Crit Care Med. 2005;33:81.
15. Auerbach AD, Goldman L. β-Blockers and reduction of cardiac events in noncardiac surgery. JAMA. 2002;287:1435-44. (Pubitemid 34250507)
16. Bederson JB, Connolly ES, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. Stroke. 2009;40:994-1025.
17. Komotar R, Schmidt J, Starke R, et al. Resuscitation and critical care of poor-grade subarachnoid hemorrhage. Neurosurgery. 2009;64:397.
18. Wartenberg KE, Schmidt JM, Temes RE, et al. Medical complications after subarachnoid hemorrhage: frequency and impact on outcome. Stroke. 2005;36:521.
19. Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;32:2012-20. (Pubitemid 32868089)
20. de Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaronson N. The clinical meaning of Rankin 'handicap' grades after stroke. Stroke. 1995;26:2027-30.
21. Scharfstein S, Neaton J, Hogan J, et al. Minimal standards in the prevention and handling of missing data in observational and experimental patient centered outcomes research. Washington, DC: Patient-Centered Outcomes Research Institute; 2012.
22. Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1994.
23. Su YS, Gelman A, Hill J, Yajima M. Multiple imputation with diagnostics (mi) in R: opening windows into the black box. J Stat Softw. 2011;45:1-31.
24. Landesberg G, Luria M, Cotev S, et al. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. The Lancet. 1993;341:715-9. (Pubitemid 23085177)
25. Dhar R. Diringer MN. Neurocrit Care: The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage; 2008.
26. Neil-Dwyer G, Walter P, Cruickshank J, Stratton C. Beta-blockade in subarachnoid haemorrhage. Drugs. 1983;25(Suppl 2):273-7.
27. Neil-Dwyer G, Walter P, Cruickshank J. β-Blockade benefits patients following a subarachnoid haemorrhage. Eur J Clin Pharmacol. 1985;28:25-9. (Pubitemid 16218639)
28. Cotton BA, Snodgrass KB, Fleming SB, et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma Acute Care Surg. 2007;62:26-35.
29. Coghlan LA, Hindman BJ, Bayman EO, et al. Independent associations between electrocardiographic abnormalities and outcomes in patients with aneurysmal subarachnoid hemorrhage findings from the intraoperative hypothermia aneurysm surgery trial. Stroke. 2009;40:412-8.
30. Mayer SA, Kurtz P, Wyman A, et al. Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: the studying the treatment of acute hypertension registry. Crit Care Med. 2011;39:2330-6.
31. Naredi S, Lambert G, Friberg P, et al. Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage. Intensive Care Med. 2006;32:1955-61. (Pubitemid 44833108)
32. Schmidt HB, Werdan K, Müller-Werdan U. Autonomic dysfunction in the ICU patient. Cur opin crit care. 2001;7:314-22.